patients who underwent mesh removal 18 were abdominal, 40 were transvaginal, 119 were cystoscopic mesh removal. For these techniques the percentage of patients who felt their symptoms were resolved compared to those unresolved were abdominal (78% vs. 22%); transvaginal (63% vs. 37%) and cystoscopic bladder (55% vs. 44%) and cystoscopic urethra (39% vs. 22%). Mesh removal was successful 85% in abdominal, 100% in transvaginal, 83% in endoscopy/ cystoscopy and 85% in cystoscopy bladder.
INTRODUCTION AND OBJECTIVES: Genitourinary injury and vaginal fistula formation are rare but devastating complications following hysterectomy. The literature regarding this topic is limited and generally focuses on ureteral injury or fistula formation alone, not in combination. We explore the combined genitourinary injury rates and risk factors for injury in a large contemporary population based dataset with long term follow-up.
METHODS: All women who underwent a hysterectomy for benign indications were identified using data from the Office of Statewide Health Planning and Development in California from [2005] [2006] [2007] [2008] [2009] [2010] [2011] . Those who underwent genitourinary repair at the time of hysterectomy or subsequent surgery for a urologic injury and/or urologic fistula were identified.
RESULTS: Of the 296,130 women who underwent hysterectomy, 5,455 (1.8%) had at least one urologic injury including: 2,817 (1.0%) ureteral injuries, 2,058 (0.70%) bladder injuries and 831 (0.3%) resultant fistulas (Figure 1 ). Of the injuries, 23.6% were unrecognized at the time of hysterectomy (104 bladder injuries, 441 ureteral injuries and 754 fistulas) ( Table 1 ). Most fistulas (90.7%) occurred without a prior history of noted genitourinary injury. In those with injuries that were repaired (either at the time of hysterectomy or in a delayed fashion), a resultant fistula developed in 2.7% of bladder repairs and 1.1% of ureteral repairs. If an injury occurred, the rate of subsequent fistula formation was lower if the injury was recognized at the time of hysterectomy (as opposed to being found later in the perioperative period) for both ureteral injuries (0.7% versus 3.4%, p<0.001) and bladder injuries (2.5% versus 6.5%, p<0.001) injuries (Figure 1 ). Multivariate modeling revealed that concomitant POP repair (OR 1.12, p[0.019), a diagnosis of endometriosis (OR 1.40 p<0.001) and surgery at a facility in the bottom quartile of hysterectomy volume (OR 1.37, p[0.049) were all associated with an increased likelihood of a genitourinary injury.
CONCLUSIONS: Of women undergoing benign hysterectomy w1.8% will have a genitourinary injury of some form. While any injury will increase the chances of a future fistula, recognizing and addressing the injury at the time it occurs reduces this risk. We identify several factors that are associated with genitourinary injury, providing insight into instances where a higher index of suspicion might be held.
Source of Funding: The Valley Medical Foundation

MP02-17 LONG-TERM REOPERATION RATES ARE EQUIVALENT FOR PELVIC ORGAN PROLAPSE REPAIRS WITH BIOLOGIC AND SYNTHETIC GRAFTS IN A LARGE POPULATION BASED COHORT
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INTRODUCTION AND OBJECTIVES:
The use of synthetic mesh to augment pelvic organ prolapse (POP) repairs has been declining due to growing concerns regarding long-term mesh specific complications. As a result, there is interest in suitable graft alternatives such as biologic materials, which possess the theoretical benefit of improved tissue remodeling with a decreased risk of persistent vaginal erosion. Limited data however exists comparing long term outcomes of biologic and synthetic grafts when used for POP repair.
METHODS: Using the California Office of Statewide Health Planning and Development database, we identified all women who underwent index inpatient POP repair with either a synthetic or biologic graft between 2005-2011 in the state of California. ICD-9 and CPT codes were used to identify subsequent surgeries in these patients for either recurrent POP or a graft complication.
RESULTS: A total of 14,192 women underwent POP repair with a biologic (14%) or synthetic graft (86%) during the study period. In the cohort, there was an overall associated repeat surgery rate of 5.6%. With a median follow-up of 2 years, women with biologic grafts had an increased risk of surgery for recurrent pelvic organ prolapse compared with synthetic mesh (3.6% vs. 2.5%, p[0.01). Conversely, women with synthetic grafts had a higher risk of repeat surgery for a graft complication (3.0% vs. 2.0%, p[0.02). There were no significant differences between the overall risk of repeat surgery in patients who received biologic versus synthetic grafts during the follow-up period (5.7% vs. 5.6%, p[0.79) (Figure 1) . CONCLUSIONS: We demonstrate in a large population-based cohort that biologic grafts are associated with an increased risk of repeat surgery for a POP recurrence while synthetic mesh is associated with an increased risk of repeat surgery for a graft related complication. These competing risks result in an equivalent overall associated repeat surgery rate between the groups suggesting that neither synthetic nor biologic grafts should be excluded based on their risk profile.
